Corbus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $4.64-$20.77 |
Market Cap | $164.4M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$50.4M |
Diluted EPS | -$4.76 |
News
See moreYahoo Finance • 10 days ago
InvenTrust Properties Breaks Below 200-Day Moving Average - Notable for IVT
Yahoo Finance • 2 months ago
Corbus Pharma's Q2 Net Loss Widens
Yahoo Finance • 4 months ago
Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab
Yahoo Finance • 4 months ago
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
About
CEO | Dr. Yuval Cohen Ph.D. |
Address | 500 River Ridge Drive, Norwood, MA, United States, 02062 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 28 |
